The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects

Programmed death ligand 1 (PD-L1) is an immune checkpoint with a role in cancer-related immune evasion. It is a target for cancer immunotherapy and its expression is detected for the use of some immune checkpoint inhibitors in advanced non-small cell lung cancer patients (NSCLC). Vimentin is a key c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravaccini, Sara, Bronte, Giuseppe, Petracci, Elisabetta, Puccetti, Maurizio, D’Arcangelo, Manolo, Ravaioli, Sara, Tumedei, Maria Maddalena, Maltoni, Roberta, Delmonte, Angelo, Cappuzzo, Federico, Crinò, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669606/
https://www.ncbi.nlm.nih.gov/pubmed/34917615
http://dx.doi.org/10.3389/fcell.2021.772216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669606/
https://www.ncbi.nlm.nih.gov/pubmed/34917615
http://dx.doi.org/10.3389/fcell.2021.772216

Ejemplares similares